NASDAQ: WAYWaystar Holding Corp Stock
$18.47+0.22 (+1.21%)
Updated Jun 18, 2026
WAY Price
$18.47
Fair Value Price
N/A
Market Cap
$3.54B
52 Week Low
$17.75
52 Week High
$41.47
P/E
26.39x
P/B
0.9x
P/S
4x
PEG
0.59x
Dividend Yield
N/A
Revenue
$1.16B
Earnings
$126.10M
Gross Margin
68.7%
Operating Margin
22.87%
Profit Margin
10.9%
Debt to Equity
0.48
Operating Cash Flow
$330M
Beta
0.81
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
WAY Overview
Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive system offers a suite of functionalities, including pre-approving finances, supporting patients with billing, overseeing claims and payments, actively preventing and recovering denied claims, enhancing revenue capture, and providing insightful analytics and reporting. The company's main clientele operates within the healthcare sector. Established in 2017, Waystar Holding Corp. is headquartered in Lehi, Utah.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine WAY's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
WAY
Ranked#15 of 44
Ranked#15 of 44
Be the first to know about important WAY news, forecast changes, insider trades & much more!
WAY News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how WAY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
WAY ($18.47) is trading above its intrinsic value of $14.13, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
WAY is poor value based on its earnings relative to its share price (26.39x), compared to the US market average (9.47x)
P/E vs Market Valuation
WAY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more WAY due diligence checks available for Premium users.
Valuation
WAY fair value
Fair Value of WAY stock based on Discounted Cash Flow (DCF)
Price
$18.47
Fair Value
$60.61
Undervalued by
69.53%
WAY ($18.47) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
WAY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
26.39x
Industry
12.86x
Market
9.47x
WAY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
WAY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
WAY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.9x
Industry
3.05x
WAY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
WAY price to earnings growth (PEG)
For valuing profitable companies with growth potential
WAY is good value based... subscribe to Premium to read more.
PEG Value Valuation
WAY's financial health
Profit margin
Revenue
$313.9M
Net Income
$43.3M
Profit Margin
13.8%
WAY's Earnings (EBIT) of $264.56M... subscribe to Premium to read more.
Interest Coverage Financials
WAY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.8B
Liabilities
$1.9B
Debt to equity
0.48
WAY's short-term assets ($386.61M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
WAY's long-term liabilities ($1.68B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
WAY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$84.9M
Investing
-$112.5M
Financing
$13.5M
WAY's operating cash flow ($330.34M)... subscribe to Premium to read more.
Debt Coverage Financials
WAY vs Health Information Service Stocks
Waystar Holding Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.